Skip to content

Clinical trials

Completed Cardiomyopathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Status: Completed Country / region: United States Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20023
20034
20046
20055
20065
20075
20085
20095
20105
20113
20127
20133
201413
20157
201611
20172
20183
20195
20204
20214
20226
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed121

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices6
Mayo Clinic6
Alnylam Pharmaceuticals4
Emory University4
Medtronic Cardiac Rhythm and Heart Failure4
National Heart, Lung, and Blood Institute (NHLBI)4
Pfizer4
University of Pittsburgh4
Washington University School of Medicine4
Duke University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies121
Heart Failure52
Amyloidosis8
Arrhythmias, Cardiac7
Cardiovascular Diseases7
Heart Diseases7
Ventricular Dysfunction6
Breast Neoplasms5
Heart Defects, Congenital5
Muscular Dystrophy, Duchenne5

Trials

Showing 1 to 25 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.